Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
1.
J Assist Reprod Genet ; 40(5): 985-994, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-37043134

RESUMO

To analyze the influence of endometrial receptivity analysis (ERA) on embryo transfer (ET) results in patients undergoing in vitro fertilization (IVF) treatment. PubMed, Embase, Cochrane Central Register of Controlled Trials, and BioMed Central databases were searched from inception up to December 2022 for studies comparing pregnancy outcomes in patients undergoing personalized embryo transfer (pET) by ERA versus standard ET. Data were pooled by meta-analysis using a random effects model. We identified twelve studies, including 14,224 patients. No differences were observed between patients undergoing ERA test and those not undergoing ERA test prior to ET in terms of live birth (OR 1.00, 95% CI 0.63-1.58, I2 = 92.7%), clinical pregnancy (OR 1.20, 95% CI 0.90-1.61, I2 = 86.5%), biochemical pregnancy (OR 0.83, 95% CI 0.46-1.49, I2 = 87%), positive pregnancy test (OR 0.99, 95% CI 0.80-1.22, I2 = 0%), miscarriage (OR 0.91, 95% CI 0.62-1.34, I2 = 67.1%), and implantation rate (OR 1.18, 95% CI 0.44-3.14, I2 = 93.2%). pET with ERA is not associated with any significant differences in pregnancy outcomes as compared to standard ET protocols. Therefore, the utility of ERA in patients undergoing IVF should be revisited.


Assuntos
Aborto Espontâneo , Resultado da Gravidez , Feminino , Gravidez , Humanos , Taxa de Gravidez , Transferência Embrionária/métodos , Aborto Espontâneo/epidemiologia , Gravidez Múltipla , Nascido Vivo , Fertilização in vitro
3.
Maturitas ; 147: 41-46, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-33832646

RESUMO

OBJECTIVE: Experimental studies suggest that lipids affect bone metabolism. We aimed to elucidate whether lipid levels are associated with bone mineral density (BMD) in a cohort of postmenopausal women. DESIGN: A cross-sectional study of participants in the Chronic Ailment Reduction after MENopause (CARMEN) cohort. Women underwent assessment of clinical and analytical parameters, including fasting lipid levels. BMD was assessed at both lumbar spine and hip. Homogeneity in the cohort was optimized by filtering out a series of confounding variables with a known impact on bone. MAIN OUTCOME MEASURES: Association of BMD at lumbar spine and femoral neck with lipid levels. RESULTS: A total of 667 of the 1304 screened women were analyzed. A strong correlation was revealed between total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) in univariate analysis. Multivariate analysis detected a significant positive association of HDL-C with BMD at both spine (p = 0.007) and femoral neck (p = 0.013). Other independent predictors of spine BMD were years since menopause (ysm, negatively associated), and body mass index (BMI) and estradiol, both positively associated with BMD. The other independent variables in the femoral neck were ysm and glucose (negatively associated) and BMI, estradiol, and phosphate, all positively associated with BMD. CONCLUSION: Levels of HDL-C, but not TC, LDL-C or triglycerides, were positively associated with BMD at both the lumbar spine and femoral neck in a homogeneous cohort of postmenopausal women.


Assuntos
Densidade Óssea , HDL-Colesterol/sangue , Colo do Fêmur , Vértebras Lombares , Pós-Menopausa/sangue , Idoso , Estudos de Coortes , Feminino , Humanos , Pessoa de Meia-Idade
4.
Nutrients ; 12(10)2020 Oct 18.
Artigo em Inglês | MEDLINE | ID: mdl-33081027

RESUMO

The rates of metabolic syndrome are increasing in parallel with the increasing prevalence of obesity, primarily due to its concomitant insulin resistance. This is particularly concerning for women, as the years around menopause are accompanied by an increase in visceral obesity, a strong determinant of insulin resistance. A fall in estrogens and increase in the androgen/estrogen ratio is attributed a determining role in this process, which has been confirmed in other physiological models, such as polycystic ovary syndrome. A healthy lifestyle, with special emphasis on nutrition, has been recommended as a first-line strategy in consensuses and guidelines. A consistent body of evidence has accumulated suggesting that the Mediterranean diet, with olive oil as a vital component, has both health benefits and acceptable adherence. Herein, we provide an updated overview of current knowledge on the benefits of olive oil most relevant to menopause-associated metabolic syndrome, including an analysis of the components with the greatest health impact, their effect on basic mechanisms of disease, and the state of the art regarding their action on the main features of metabolic syndrome.


Assuntos
Dieta Saudável , Dieta Mediterrânea , Envelhecimento Saudável , Estilo de Vida Saudável , Menopausa , Síndrome Metabólica/etiologia , Síndrome Metabólica/metabolismo , Fenômenos Fisiológicos da Nutrição/fisiologia , Azeite de Oliva , Idoso , Androgênios/metabolismo , Estrogênios/metabolismo , Feminino , Humanos , Resistência à Insulina , Síndrome Metabólica/terapia , Pessoa de Meia-Idade , Obesidade Abdominal/etiologia , Obesidade Abdominal/metabolismo , Obesidade Abdominal/terapia
5.
Maturitas ; 136: 25-37, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32386663

RESUMO

Diet is a crucial variable for a healthy life. A rapidly growing number of studies in recent years support the hypothesis that the Mediterranean diet (MedDiet) has a beneficial effect on certain body systems, but the highly varied objectives and quality of these publications warrants an updated assessment. In the present review we performed a comprehensive evaluation of current evidence on the impact of the MedDiet on human health, assessing its effect on the incidence or progression of the main non-communicable diseases and their intermediate outcomes and risk factors. We scrutinised the clinical evidence from observational studies and randomised controlled trials. Cardiovascular disease was the condition with most information. The MedDiet showed a general preventive effect, which was reproduced to varying degrees for certain intermediate cardiovascular outcomes such as blood pressure, lipids, obesity, metabolic syndrome and diabetes. Benefits were also found for several types of cancer, brain function (including cognition, mood and to a lesser extent Parkinson's disease) and mortality. The quality of the published evidence was, however, generally moderate or low. In conclusion, the MedDiet shows a favourable impact on health. General adoption of a MedDiet is concordant with current policies promoting healthy and sustainable nutrition worldwide. Nonetheless, more high-quality research is needed to improve the consistency of the findings.


Assuntos
Dieta Mediterrânea , Doenças Cardiovasculares/epidemiologia , Cognição , Diabetes Mellitus/epidemiologia , Estudos Epidemiológicos , Humanos , Menopausa , Neoplasias/epidemiologia , Estudos Observacionais como Assunto , Osteoporose/epidemiologia , Ensaios Clínicos Controlados Aleatórios como Assunto
6.
Maturitas ; 132: 65-69, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-31883665

RESUMO

The Mediterranean diet (MedDiet) represents the crystallisation of the centuries-old cooking legacies of different civilisations. The association of the MedDiet with longevity and low cardiovascular risk prompted the Seven Countries Study, which provided epidemiological evidence on the health effects of diet. This led to further studies, both epidemiological and interventional. Scales to measure adherence as well as studies of food components have consolidated a body of knowledge that is of great interest to institutions and governmental agencies. The recognition of its benefits for health has made the widespread introduction of the MedDiet an urgent challenge. Parallel efforts are being made to extend research through experimental and clinical studies. The purpose of this review is to present the historical background of the MedDiet, the main steps leading to the recognition of its health benefits, and the current strategy to facilitate its global implementation.


Assuntos
Dieta Mediterrânea , Alimentos , Humanos , Longevidade
8.
Gynecol Oncol Rep ; 17: 16-9, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27354994

RESUMO

We report a case of solitary fibrous tumor (SFT) of greater omentum in a young woman. SFT arising from the greater omentum can mimic a gynecologic neoplasm. SFTs are generally benign but some of them are malignant and have uncertain prognosis. An adequate follow-up is essential in these patients.

10.
Fertil Steril ; 98(3): 529-55, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22938768

RESUMO

To assess the literature on preclinical and clinical efficacy and safety data of pharmacologic groups proposed in the treatment of endometriosis, we performed a systematic review of publications from March 2002 to January 2012 via PubMed search. Additional relevant articles were identified from citations within these publications. A high number of medications were tested in preclinical models of endometriosis due to their theoretic capacity of disrupting important pathophysiologic pathways of the disease, such as inflammatory response, angiogenesis and cell survival, proliferation, migration, adhesion, and invasion. Tumor necrosis factor α-blockers, nuclear factor κB inhibitors, antiangiogenic agents, statins, antioxidants, immunomodulators, flavonoids, histone deacetylase inhibitors, matrix metalloproteinase inhibitors, metformin, novel modulators of sex steroids expression, and apoptotic agents were all effective in in vitro/animal models. Most of these agents have not been tried in the clinical setting, mainly because of the high risk of adverse effects. However, some of them can be used in humans. Dopamine agonists and valproic acid have already been tested in pilot studies with good results. Etanercept, metformin, and statins are used in humans for other indications, and endostatin is now being tested in phase 2 oncologic trials. These drugs may constitute alternatives to conventional therapy with estrogen inhibitors and anti-inflammatory agents.


Assuntos
Endometriose/tratamento farmacológico , Inibidores da Angiogênese/uso terapêutico , Animais , Anti-Inflamatórios/uso terapêutico , Antioxidantes/uso terapêutico , Feminino , Humanos , Ácido Hialurônico/uso terapêutico , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Melatonina/uso terapêutico , NF-kappa B/antagonistas & inibidores , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Proteínas Quinases p38 Ativadas por Mitógeno/antagonistas & inibidores
11.
Case Rep Obstet Gynecol ; 2012: 954241, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23259097

RESUMO

We present a case of a twin pregnancy in which one fetus developed a rapidly growing unilateral intrathoracic tumor. While a cystic adenomatoid malformation was suspected in the ultrasound scan, the magnetic resonance scan suggested a pulmonary blastoma or a bronchioalveolar carcinoma. Postnatal chest radiography and contrast-enhanced computed tomography of the affected newborn were performed, and it was ruled out the possibility of malignant origin. Finally, the anatomopathologic exam revealed the presence of a mesenchymal hamartoma in the chest wall. Nevertheless, parents refused any treatment for the newborn.

12.
Case Rep Obstet Gynecol ; 2012: 726732, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23198198

RESUMO

Arthrogryposis multiplex congenital is a rare condition defined as contractures in multiple joints at birth due to disorders starting in fetal life. Its etiology is associated with many different conditions and in many instances remains unknown. The final common pathway to all of them is decreased fetal movement (fetal akinesia) due to an abnormal intrauterine environment. Causes of decreased fetal movements may be neuropathic abnormalities, abnormalities of connective tissue or muscle, intrauterine vascular compromise, maternal diseases, and space limitations within the uterus. When the cause of arthrogryposis is space limitations in uterus, the most common etiology is oligohydramnios. The same can result from intrauterine tumours as fibroids, although to our knowledge there are only two papers reporting cases of fetal deformities related to uterine leiomyomas. We describe a well-documented exceptional case of arthrogryposis associated with the presence of a large uterine fibroid. It could illustrate the importance of a careful and appropriate assessment of uterine fibroids before and in the course of a pregnancy considering that they can cause both serious maternal and fetal complications.

13.
Prog. obstet. ginecol. (Ed. impr.) ; 60(3): 232-235, mayo-jun. 2017. ilus
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-164067

RESUMO

El síndrome de Turner es la alteración cromosómica más frecuente de los caracteres sexuales. Puede ser sospechado intraútero mediante ecografía por la frecuente presencia de malformaciones fetales asociadas, siendo las más habituales las cardiacas, renales y esqueléticas. Excepcionalmente se han descrito malformaciones del sistema nervioso central en fetos con síndrome de Turner. Presentamos el primer caso publicado hasta el momento de un feto acráneo afectado por síndrome de Turner. Como han señalado diversos estudios, la presencia de malformaciones fetales del sistema nervioso central debe hacer sospechar la presencia de aneuplodías (AU)


Turner’s síndrome is the most common sex chromosome abnormality. It may be suspected in utero by ultrasound by the frequent presence of associated fetal malformations, the most common being congenital heart defects, renal abnormalities and skeletal anomalies. Rarely central nervous system malformations have been described in fetuses with Turner’s syndrome. We present the first reported case of anacranial fetus affected by Turner’s syndrome. As noted by different studies, the presence of fetal malformations of the central nervous system should alert the presence of aneuploidies (AU)


Assuntos
Humanos , Feminino , Gravidez , Síndrome de Turner/complicações , Síndrome de Turner , Anencefalia , Ultrassonografia Pré-Natal/métodos , Anormalidades Congênitas , Feto/anormalidades , Primeiro Trimestre da Gravidez/efeitos da radiação , Diagnóstico Precoce , Cariótipo , Prognóstico , Ultrassonografia Pré-Natal/tendências
14.
Front Biosci (Schol Ed) ; 3(1): 191-204, 2011 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-21196369

RESUMO

Phytoestrogens are a group of non-steroidal compounds of plant origin that present structural and functional similarities with estradiol. Isoflavones are their most widely known category. There are different mechanisms of action of isoflavones accepted, although they may be considered as selective modulators of estrogen receptors. On the other hand, Cimicifuga Racemosa is a perennial plant used traditionally for problems related to menstruation. Its action mechanisms have not been totally identified. There is a growing interest in the usefulness of phytotherapy in the treatment of symptoms and menopause-related diseases. Isoflavones and Cimicifuga Racemosa moderately improve vasomotor symptoms in menopausal women, particularly in those who have a greater number of hot flushes. Furthermore, trials performed with soy isoflavones have observed a reduction of the loss of bone mineral density in postmenopausal women and a slight decrease in LDL cholesterol. In short, phytotherapy will constitute a therapeutic option that can offer assistance to women who want to improve their quality of life through relief of vasomotor symptoms or benefit from other effects for their health.


Assuntos
Cimicifuga/química , Terapia de Reposição de Estrogênios/métodos , Isoflavonas/uso terapêutico , Menopausa/efeitos dos fármacos , Fitoestrógenos/uso terapêutico , Fitoterapia/métodos , Extratos Vegetais/uso terapêutico , Densidade Óssea/efeitos dos fármacos , Neoplasias da Mama/prevenção & controle , Endométrio/efeitos dos fármacos , Feminino , Humanos , Isoflavonas/farmacologia , Fitoestrógenos/farmacologia , Extratos Vegetais/farmacologia , Fatores de Risco , Sistema Vasomotor/efeitos dos fármacos
15.
Fertil Steril ; 95(7): 2433.e1-3, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21377151

RESUMO

OBJECTIVE: To report the exceptional condition of retroperitoneal ectopic pregnancy after intrauterine insemination. DESIGN: Case report. SETTING: University hospital. PATIENT(S): A 37-year-old woman, gravida 2, para 1, presented to the emergency department 1 month after intrauterine insemination complaining of lower abdominal pain. INTERVENTION(S): A transvaginal ultrasound assessment revealed a complex mass containing a gestational sac with vitelline vesicle behind the left ovary. At laparoscopy, a nodular lesion was seen next to the left uterosacral ligament, suggesting the presence of an ectopic pregnancy in the retroperitoneal space. MAIN OUTCOME MEASURE(S): The unusual location of an ectopic pregnancy such as in the retroperitoneum should be examined in patients with clinical findings that suggest ectopic pregnancy if both the uterus and adnexa are normal during laparoscopic exploration. RESULT(S): The patient's retroperitoneal pregnancy was treated with a wide laparoscopic excision. To allow the removal of all trophoblastic tissue, a 3×2×2 cm hemorrhagic mass containing the ectopic pregnancy was removed from the retroperitoneal space. Retroperitoneal ectopic pregnancy was confirmed by the pathology diagnosis. CONCLUSION(S): Retroperitoneal pregnancy after assisted reproductive techniques is an exceptional condition that must be considered in patients with clinical findings that suggest ectopic pregnancy if both the uterus and adnexa are normal during laparoscopic exploration.


Assuntos
Infertilidade Feminina/terapia , Inseminação Artificial/efeitos adversos , Gravidez Ectópica/etiologia , Dor Abdominal/etiologia , Abortivos não Esteroides/uso terapêutico , Adulto , Feminino , Humanos , Infertilidade Feminina/etiologia , Laparoscopia , Metotrexato/uso terapêutico , Gravidez , Gravidez Ectópica/diagnóstico , Gravidez Ectópica/cirurgia , Espaço Retroperitoneal , Resultado do Tratamento
17.
Interact Cardiovasc Thorac Surg ; 11(5): 713-4, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20716556

RESUMO

Simultaneous gastric and diaphragmatic rupture is an exceptional situation during pregnancy and it implies a high-risk of maternal and fetal mortality. They are usually associated with previous diaphragmatic abnormalities such as diaphragmatic hernia or diaphragmatic eventration. Both gastric and diaphragmatic rupture can be triggered by situations involving high intra-abdominal pressure. We present the case of a 35-year-old pregnant woman presenting an unspecific clinical picture of intense chest pain and hypoventilation at 15 weeks of pregnancy. She was diagnosed with diaphragmatic rupture complicated by a gastric rupture.


Assuntos
Eventração Diafragmática/complicações , Hérnia Diafragmática/diagnóstico , Complicações na Gravidez/diagnóstico , Ruptura Gástrica/diagnóstico , Adulto , Cesárea , Dor no Peito/etiologia , Feminino , Hérnia Diafragmática/etiologia , Hérnia Diafragmática/cirurgia , Humanos , Hipoventilação/etiologia , Nascido Vivo , Gravidez , Complicações na Gravidez/etiologia , Complicações na Gravidez/cirurgia , Pressão , Ruptura Gástrica/etiologia , Ruptura Gástrica/cirurgia , Toracotomia , Tomografia Computadorizada por Raios X
18.
J Ophthalmol ; 2010: 423672, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-21048998

RESUMO

Influenza H1N1 or A virus is a new virus serotype capable of human-to-human transmission. This infection causes a flu syndrome similar to that of seasonal influenza, with only one case of conjunctivitis described and no clinical details or microbiological confirmation. Its diagnosis is performed by PCR of pharyngeal smear of the patients affected. We report the first well-documented case in the medical literature of conjunctivitis by H1N1 virus.

SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa